(LVTX) – Hot FDA News
-
LAVA (LVTX) Announces Clinical Development Milestone Achieved by Pfizer for PF-08046052
-
LAVA Therapeutics (LVTX) Announces Collaboration with Merck & Co., Inc., Rahway, NJ, USA to Evaluate LAVA-1207 in Combination with KEYTRUDA
Back to LVTX Stock Lookup